Answers are grounded in this paper and cite their sources.
This study examines how isosorbide dinitrate and l-arginine mitigate oxidative stress and histopathological changes in animal models, suggesting potential therapeutic roles.
In this study, the effects of the nitric oxide donor isosorbide dinitrate (ISDN) and the nitric oxide precursor L-arginine on oxidative stress and histopathological changes induced by 96% ethanol in the brain, liver and gastric tissue were examined. Rats were treated with either ISDN (5 or 10 mg/kg) or L-arginine (200 or 400 mg/kg), given orally 30 min before ethanol (1.5 ml, p.o.) and euthanized 2h after ethanol administration. Oxidative stress biomarkers; malondialdehyde, reduced glutathione, nitric oxide and paraoxonase-1 activity were determined in brain and liver. In addition, brain, liver and gastric mucosal histopathology was done. Results showed that ethanol treated rats exhibited a significant elevation in levels of malondialdehyde (lipid peroxidation), and nitric oxide along with a significant decrease in reduced glutathione and paraoxonase-1 activity in brain and liver tissue. ISDN or L-arginine given prior to ethanol -treated animals, resulted in a significant decrease in malondialdehyde and nitric oxide in a dose-dependent manner. Moreover, a significantly raised reduced glutathione levels and paraoxonase-1 activities in both the brain and liver were observed with respect to ethanol control values. The histological study indicated that either ISDN or L-arginine protected against brain, liver and gastric mucosal damage. These data provide evidence that ISDN and L-arginine could protect against the toxic effects of ethanol by attenuating oxidative stress.
No takes yet. Share an insight, caveat, or question.
Abdel‐Salam et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: